menin inhibitor azd3632
Generic: Menin Inhibitor AZD3632
menin inhibitor azd3632: 1 clinical trial tracked.
menin inhibitor azd3632 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about menin inhibitor azd3632, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence0 indications · 1 study sponsors
Related indications
No linked indication is available.
Study sponsors
Clinical Trial Registry Records (1)
A Modular Phase I/II, Open-label, Multi-Centre Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Primary endpoint: Module 1: Number of participants with dose-limiting toxicity (DLT)
Interventionalopen84 targetStarted 2026-01Completion 2029-0230 sites · Australia, Canada, Denmark, Germany…AstraZeneca